Human Antibodies
ISSN: 1093-2607
Volume 20; 4 issues
Institutional subscription (print and online) for 2011: €553 / US$750 (including postage and handling)
Click on the subscribe button for more options, including personal subscription prices.
Status Report: Last issue (volume 20:1-2) online on 10 May 2011
Next issue (volume 20:3) scheduled for August 2011

Aims and Scope
Editorial Board
Submission of Manuscripts
Abstracted in

Download flyer for this journal

Mark C. Glassy PhD
Integrated Medical Sciences Association Foundation (IMSA)
10246 Parkdale Avenue
San Diego, CA 92126
Tel.: +1 858 566 9490

Editorial Board
Andrew Bradbury, Los Alamos, NM , USA Nils Lonberg, San Jose, CA, USA
Dennis Burton, La Jolla, CA , USA Jim Marks, San Francisco, CA, USA
J.D. Capra, Oklahoma City, OK, USA Sherie L. Morrison, Los Angeles, CA, USA
Joe Chiba, Chiba, Japan Paul Parren, Utrecht, The Netherlands
Stefan Dubel, Braunschweig, Germany Andreas Plueckthun, Zürich, Switzerland
Miroslaw K. Gorny, New York, NY, USA Kathleen N. Potter, Southampton, United Kingdom
Hennie R. Hoogenboom, Liege, Belgium Matthew D. Scharff, Bronx, NY, USA
Peter Hudson, Parkville, Australia Yehuda Shoenfeld, Tel-Hashomer, Israel
Isao Ishida, Shibuya-ku.Tokyo, Japan Michael Steinitz, Jerusalem, Israel
Zdenka L. Jonak, King of Prussia, PA, USA Freda Stevenson, Southampton, United Kingdom
Angray S. Kang, University of Biosciences Louis M. Weiner, Washington, DC, USA
Alois B. Lang, Berne, Switzerland Greg Winter, Cambridge, United Kingdom
James W. Larrick, Mountain View, VA, USA K.D. Wittrup, Cambridge, MA, USA

Submission of Manuscripts 
See instructions to authors.
Aims and Scope 
Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications. Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.
Abstracted in
EBSCO database, Pubmed, article@inist, ulrich's periodicals

IOS Press
Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
Tel.: +31 20 688 3355, Fax: +31 20 687 0019